Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj
CAS TSIS TAU: 503612-47-3
Cov Qauv Nqaij: C25H25N5O4
Cov Nqa Molecular: 459.497
EINECS TSIS MUAJ: 639-684-6
MDL TSIS TAU: MFCD11977295
Cov Khoom Qhia:
Khoom npe: Apixaban CAS TSIS TAU: 503612-47-3
Txhais:
1- (4-methoxyphenyl) -7-oxo-6- [4- (2-oxopiperidin-1-yl) phenyl] -4,5-dihydropyrazolo [3,4-c] pyridine-3-carboxamide;
Tshuaj& Cov Khoom Uas Lub Cev:
Zog: cov hmoov dawb crystalline
Ntsuas: ≥99.0%
Qhov ceev: 1.42g / cm3
Lub Ntsiab Kub: 770.5 ℃ ntawm 760 mmHg
Flash Point: 419.8 ℃
Apixaban yog hom tshiab ntawm qhov ncauj qhov Xa Xa Txoj Haujlwm sib koom tes tsim los ntawm Bristol-Myers Squibb thiab Pfizer. Nws yog hom tshiab ntawm cov tshuaj tiv thaiv qhov ncauj. Los ntawm inhibiting qhov tseem ceeb txhaws feem Xa, Apixaban tuaj yeem tiv thaiv thrombin tiam thiab thrombosis.
Thaum Lub Plaub Hlis 26, 2007, Bristol-Myers Squibb thiab Pfizer tau tshaj tawm txog kev koom tes los tsim kho qhov ncauj tshuaj tiv thaiv tshiab, apixaban muaj los ntawm Bristol-Myers Squibb, raws li kev hloov kho khoom lag luam rau warfarin.
Thaum lub Tsib Hlis 2011, Apixaban yog thawj zaug tau pom zoo rau kev tiv thaiv kev mob venous hauv cov neeg mob cov neeg laus uas tau xaiv kho lub ntsag lossis hauv caug hloov phais hauv 27 EU lub tebchaws, Iceland thiab Norway.
Thaum Lub Kaum Ib Hlis 20, 2012, European Commission tau pom zoo aletto (apixaban) rau kev tiv thaiv kab mob stroke thiab systembol embolism hauv cov neeg laus uas tsis-valvular atrial fibrillation (NVAF) nrog ib lossis ntau qhov kev pheej hmoo. Tom qab ntawd, Lub Koomhaum Canadian Tshuaj, Nyij Pooj, thiab Asmeskas FDA pom zoo (Apixaban) rau kev tiv thaiv mob stroke thiab cov qe ntshav rau cov neeg laus uas tsis-valvular atrial fibrillation (NVAF) nrog ib lossis ntau qhov kev pheej hmoo.
Thaum Lub Plaub Hlis 12, 2013, cov tshuaj tiv thaiv kev tsis haum tshuaj tshiab ELIQUIS (Apixaban) koom tes tsim los ntawm Bristol-Myers Squibb thiab Pfizer tau tshaj tawm tias yuav pib ua hauv Suav teb.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov hu rau peb!
Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.
Cim npe nrov: apixaban cas 503612-47-3, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag